×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SPRY – ars pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SPRY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/1
01:35 am
spry
How Recent Developments Are Shaping the Story for ARS Pharmaceuticals According to Analysts [Yahoo! Finance]
Low
Report
How Recent Developments Are Shaping the Story for ARS Pharmaceuticals According to Analysts [Yahoo! Finance]
11/26
08:28 am
spry
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/26
08:00 am
spry
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
Low
Report
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
11/22
07:57 am
spry
ARS Pharmaceuticals (NASDAQ:SPRY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
ARS Pharmaceuticals (NASDAQ:SPRY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/16
10:26 pm
spry
Why Analysts See the ARS Pharmaceuticals Story Shifting Amid Changing Growth and Market Risks [Yahoo! Finance]
High
Report
Why Analysts See the ARS Pharmaceuticals Story Shifting Amid Changing Growth and Market Risks [Yahoo! Finance]
11/10
04:41 pm
spry
ARS Pharma SPRY Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
ARS Pharma SPRY Q3 2025 Earnings Call Transcript [Yahoo! Finance]
11/10
02:04 pm
spry
ARS Pharmaceuticals: What We Learned From Q3 Earnings - Why I Maintain Hold Rating [Seeking Alpha]
Medium
Report
ARS Pharmaceuticals: What We Learned From Q3 Earnings - Why I Maintain Hold Rating [Seeking Alpha]
11/10
06:11 am
spry
ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray) [Yahoo! Finance]
Low
Report
ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray) [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
06:00 am
spry
ars pharmaceuticals, inc.
MISS
Report
-1.1%
ars pharmaceuticals, inc.
8/13/2025
07:00 am
spry
ars pharmaceuticals, inc.
MISS
Report
-9.9%
ars pharmaceuticals, inc.
5/14/2025
07:00 am
spry
ars pharmaceuticals, inc.
IN-LINE
Report
-9.8%
ars pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
11/14
06:44 pm
spry
Form 4 ARS Pharmaceuticals, For: Nov 13 Filed by: Dorsey Brian
High
Report
Form 4 ARS Pharmaceuticals, For: Nov 13 Filed by: Dorsey Brian
11/14
06:43 pm
spry
Form 4 ARS Pharmaceuticals, For: Nov 12 Filed by: Chakma Justin
High
Report
Form 4 ARS Pharmaceuticals, For: Nov 12 Filed by: Chakma Justin
11/14
06:42 pm
spry
Form 4 ARS Pharmaceuticals, For: Nov 12 Filed by: Shah Pratik
High
Report
Form 4 ARS Pharmaceuticals, For: Nov 12 Filed by: Shah Pratik
11/12
05:26 pm
spry
Form 144 ARS Pharmaceuticals, Filed by: Chakma Justin
Medium
Report
Form 144 ARS Pharmaceuticals, Filed by: Chakma Justin
11/12
11:10 am
spry
Form 144/A ARS Pharmaceuticals, Filed by: Chakma Justin
Low
Report
Form 144/A ARS Pharmaceuticals, Filed by: Chakma Justin
11/12
10:56 am
spry
Form 144 ARS Pharmaceuticals, Filed by: Chakma Justin
Low
Report
Form 144 ARS Pharmaceuticals, Filed by: Chakma Justin
11/10
06:05 am
spry
Form 10-Q ARS Pharmaceuticals, For: Sep 30
Low
Report
Form 10-Q ARS Pharmaceuticals, For: Sep 30
11/10
06:03 am
spry
Form 8-K ARS Pharmaceuticals, For: Nov 10
Low
Report
Form 8-K ARS Pharmaceuticals, For: Nov 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: